Impact of genetic counseling and testing in individuals at high risk of familial Alzheimer's disease from Latin America: a non‐randomized controlled trial

Abstract INTRODUCTION This study involved evaluating a tailored genetic counseling and testing (GCT) protocol for families at risk of autosomal dominant Alzheimer's disease (ADAD) in Latin America (LatAm), focusing on essential cultural and regional adaptations. METHODS We conducted a non‐rando...

Full description

Saved in:
Bibliographic Details
Main Authors: Pablo M. Bagnati, Marisol Londoño Castaño, María Laura Fernández, Beatriz Mora Henao, Patricio Chrem, David Aguillón, Luz Estela Varela, Juan Diego Barbaran, Yudy Leon, Ezequiel Surace, Claudia C. Madrigal, Juan Pablo Picasso, Claudia P. Ramos, Carlos M. Restrepo Fernández, Gabriela Vigo, Laura Ramirez Aguilar, Gabriel Alberto VargasCuadros, Mauricio Arcos‐Burgos, Erika Mariana Longoria, Ellen Ziegemeier, Eric McDade, Randall J. Bateman, Ricardo F. Allegri, Francisco Lopera, Jorge J. Llibre‐Guerra
Format: Article
Language:English
Published: Wiley 2025-04-01
Series:Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring
Subjects:
Online Access:https://doi.org/10.1002/dad2.70102
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849683280342810624
author Pablo M. Bagnati
Marisol Londoño Castaño
María Laura Fernández
Beatriz Mora Henao
Patricio Chrem
David Aguillón
Luz Estela Varela
Juan Diego Barbaran
Yudy Leon
Ezequiel Surace
Claudia C. Madrigal
Juan Pablo Picasso
Claudia P. Ramos
Carlos M. Restrepo Fernández
Gabriela Vigo
Laura Ramirez Aguilar
Gabriel Alberto VargasCuadros
Mauricio Arcos‐Burgos
Erika Mariana Longoria
Ellen Ziegemeier
Eric McDade
Randall J. Bateman
Ricardo F. Allegri
Francisco Lopera
Jorge J. Llibre‐Guerra
author_facet Pablo M. Bagnati
Marisol Londoño Castaño
María Laura Fernández
Beatriz Mora Henao
Patricio Chrem
David Aguillón
Luz Estela Varela
Juan Diego Barbaran
Yudy Leon
Ezequiel Surace
Claudia C. Madrigal
Juan Pablo Picasso
Claudia P. Ramos
Carlos M. Restrepo Fernández
Gabriela Vigo
Laura Ramirez Aguilar
Gabriel Alberto VargasCuadros
Mauricio Arcos‐Burgos
Erika Mariana Longoria
Ellen Ziegemeier
Eric McDade
Randall J. Bateman
Ricardo F. Allegri
Francisco Lopera
Jorge J. Llibre‐Guerra
author_sort Pablo M. Bagnati
collection DOAJ
description Abstract INTRODUCTION This study involved evaluating a tailored genetic counseling and testing (GCT) protocol for families at risk of autosomal dominant Alzheimer's disease (ADAD) in Latin America (LatAm), focusing on essential cultural and regional adaptations. METHODS We conducted a non‐randomized controlled trial among ADAD families in Colombia and Argentina. Participants were categorized based on their decision to learn their genetic status (GS), with further comparisons between mutation‐positive versus mutation‐negative participants who learned their status. Psychological impacts were measured using validated scales for anxiety and depression. RESULTS Of the 122 eligible participants, 97 completed the GCT protocol, and 87 opted to learn their GS. There were no clinically significant differences in psychological distress between those who learned their status and those who did not, nor between mutation‐positive and mutation‐negative individuals. DISCUSSION The GCT protocol effectively managed psychological impacts in ADAD families and was positively received, demonstrating the importance of culturally adapted GCT protocols. Highlights We examined the adaptation and efficacy of a GCT protocol in LatAm for families at risk of ADAD. The GCT protocol mitigated psychological distress among at‐risk ADAD families. The study confirms the protocol's cultural appropriateness and psychological safety. Future studies should explore the long‐term psychological and public health impacts of GCT and use of GCT for treatment options.
format Article
id doaj-art-2fceca5cd19c46babca461486fd77fb6
institution DOAJ
issn 2352-8729
language English
publishDate 2025-04-01
publisher Wiley
record_format Article
series Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring
spelling doaj-art-2fceca5cd19c46babca461486fd77fb62025-08-20T03:23:57ZengWileyAlzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring2352-87292025-04-01172n/an/a10.1002/dad2.70102Impact of genetic counseling and testing in individuals at high risk of familial Alzheimer's disease from Latin America: a non‐randomized controlled trialPablo M. Bagnati0Marisol Londoño Castaño1María Laura Fernández2Beatriz Mora Henao3Patricio Chrem4David Aguillón5Luz Estela Varela6Juan Diego Barbaran7Yudy Leon8Ezequiel Surace9Claudia C. Madrigal10Juan Pablo Picasso11Claudia P. Ramos12Carlos M. Restrepo Fernández13Gabriela Vigo14Laura Ramirez Aguilar15Gabriel Alberto VargasCuadros16Mauricio Arcos‐Burgos17Erika Mariana Longoria18Ellen Ziegemeier19Eric McDade20Randall J. Bateman21Ricardo F. Allegri22Francisco Lopera23Jorge J. Llibre‐Guerra24Department of Cognitive Neurology Neuropsychiatry and Neuropsychology Fleni Neurological Research Institute Buenos Aires ArgentinaGrupo de Neurociencias de Antioquia Facultad de Medicina Universidad de Antioquia Medellín ColombiaDepartment of Cognitive Neurology Neuropsychiatry and Neuropsychology Fleni Neurological Research Institute Buenos Aires ArgentinaFundación Médica de Enfermedades Raras Medellín ColombiaDepartment of Cognitive Neurology Neuropsychiatry and Neuropsychology Fleni Neurological Research Institute Buenos Aires ArgentinaGrupo de Neurociencias de Antioquia Facultad de Medicina Universidad de Antioquia Medellín ColombiaFundación Médica de Enfermedades Raras Medellín ColombiaFundación Médica de Enfermedades Raras Medellín ColombiaGrupo de Neurociencias de Antioquia Facultad de Medicina Universidad de Antioquia Medellín ColombiaDepartment of Cognitive Neurology Neuropsychiatry and Neuropsychology Fleni Neurological Research Institute Buenos Aires ArgentinaGrupo de Neurociencias de Antioquia Facultad de Medicina Universidad de Antioquia Medellín ColombiaDepartment of Cognitive Neurology Neuropsychiatry and Neuropsychology Fleni Neurological Research Institute Buenos Aires ArgentinaGrupo de Neurociencias de Antioquia Facultad de Medicina Universidad de Antioquia Medellín ColombiaFundación Médica de Enfermedades Raras Medellín ColombiaServicio de Neurología Hospital San Bernardo Salta ArgentinaGrupo de Neurociencias de Antioquia Facultad de Medicina Universidad de Antioquia Medellín ColombiaFundación Médica de Enfermedades Raras Medellín ColombiaGrupo de Neurociencias de Antioquia Facultad de Medicina Universidad de Antioquia Medellín ColombiaCognitive Neurosciences Lab National Institute of Neurology and Neurosurgery Mexico City MexicoDepartment of Neurology Washington University School of Medicine St Louis Missouri USADepartment of Neurology Washington University School of Medicine St Louis Missouri USADepartment of Neurology Washington University School of Medicine St Louis Missouri USADepartment of Cognitive Neurology Neuropsychiatry and Neuropsychology Fleni Neurological Research Institute Buenos Aires ArgentinaGrupo de Neurociencias de Antioquia Facultad de Medicina Universidad de Antioquia Medellín ColombiaDepartment of Neurology Washington University School of Medicine St Louis Missouri USAAbstract INTRODUCTION This study involved evaluating a tailored genetic counseling and testing (GCT) protocol for families at risk of autosomal dominant Alzheimer's disease (ADAD) in Latin America (LatAm), focusing on essential cultural and regional adaptations. METHODS We conducted a non‐randomized controlled trial among ADAD families in Colombia and Argentina. Participants were categorized based on their decision to learn their genetic status (GS), with further comparisons between mutation‐positive versus mutation‐negative participants who learned their status. Psychological impacts were measured using validated scales for anxiety and depression. RESULTS Of the 122 eligible participants, 97 completed the GCT protocol, and 87 opted to learn their GS. There were no clinically significant differences in psychological distress between those who learned their status and those who did not, nor between mutation‐positive and mutation‐negative individuals. DISCUSSION The GCT protocol effectively managed psychological impacts in ADAD families and was positively received, demonstrating the importance of culturally adapted GCT protocols. Highlights We examined the adaptation and efficacy of a GCT protocol in LatAm for families at risk of ADAD. The GCT protocol mitigated psychological distress among at‐risk ADAD families. The study confirms the protocol's cultural appropriateness and psychological safety. Future studies should explore the long‐term psychological and public health impacts of GCT and use of GCT for treatment options.https://doi.org/10.1002/dad2.70102autosomal dominant Alzheimer's diseasecultural adaptationgenetic counseling and testingLatin Americapsychological impactvulnerabilities
spellingShingle Pablo M. Bagnati
Marisol Londoño Castaño
María Laura Fernández
Beatriz Mora Henao
Patricio Chrem
David Aguillón
Luz Estela Varela
Juan Diego Barbaran
Yudy Leon
Ezequiel Surace
Claudia C. Madrigal
Juan Pablo Picasso
Claudia P. Ramos
Carlos M. Restrepo Fernández
Gabriela Vigo
Laura Ramirez Aguilar
Gabriel Alberto VargasCuadros
Mauricio Arcos‐Burgos
Erika Mariana Longoria
Ellen Ziegemeier
Eric McDade
Randall J. Bateman
Ricardo F. Allegri
Francisco Lopera
Jorge J. Llibre‐Guerra
Impact of genetic counseling and testing in individuals at high risk of familial Alzheimer's disease from Latin America: a non‐randomized controlled trial
Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring
autosomal dominant Alzheimer's disease
cultural adaptation
genetic counseling and testing
Latin America
psychological impact
vulnerabilities
title Impact of genetic counseling and testing in individuals at high risk of familial Alzheimer's disease from Latin America: a non‐randomized controlled trial
title_full Impact of genetic counseling and testing in individuals at high risk of familial Alzheimer's disease from Latin America: a non‐randomized controlled trial
title_fullStr Impact of genetic counseling and testing in individuals at high risk of familial Alzheimer's disease from Latin America: a non‐randomized controlled trial
title_full_unstemmed Impact of genetic counseling and testing in individuals at high risk of familial Alzheimer's disease from Latin America: a non‐randomized controlled trial
title_short Impact of genetic counseling and testing in individuals at high risk of familial Alzheimer's disease from Latin America: a non‐randomized controlled trial
title_sort impact of genetic counseling and testing in individuals at high risk of familial alzheimer s disease from latin america a non randomized controlled trial
topic autosomal dominant Alzheimer's disease
cultural adaptation
genetic counseling and testing
Latin America
psychological impact
vulnerabilities
url https://doi.org/10.1002/dad2.70102
work_keys_str_mv AT pablombagnati impactofgeneticcounselingandtestinginindividualsathighriskoffamilialalzheimersdiseasefromlatinamericaanonrandomizedcontrolledtrial
AT marisollondonocastano impactofgeneticcounselingandtestinginindividualsathighriskoffamilialalzheimersdiseasefromlatinamericaanonrandomizedcontrolledtrial
AT marialaurafernandez impactofgeneticcounselingandtestinginindividualsathighriskoffamilialalzheimersdiseasefromlatinamericaanonrandomizedcontrolledtrial
AT beatrizmorahenao impactofgeneticcounselingandtestinginindividualsathighriskoffamilialalzheimersdiseasefromlatinamericaanonrandomizedcontrolledtrial
AT patriciochrem impactofgeneticcounselingandtestinginindividualsathighriskoffamilialalzheimersdiseasefromlatinamericaanonrandomizedcontrolledtrial
AT davidaguillon impactofgeneticcounselingandtestinginindividualsathighriskoffamilialalzheimersdiseasefromlatinamericaanonrandomizedcontrolledtrial
AT luzestelavarela impactofgeneticcounselingandtestinginindividualsathighriskoffamilialalzheimersdiseasefromlatinamericaanonrandomizedcontrolledtrial
AT juandiegobarbaran impactofgeneticcounselingandtestinginindividualsathighriskoffamilialalzheimersdiseasefromlatinamericaanonrandomizedcontrolledtrial
AT yudyleon impactofgeneticcounselingandtestinginindividualsathighriskoffamilialalzheimersdiseasefromlatinamericaanonrandomizedcontrolledtrial
AT ezequielsurace impactofgeneticcounselingandtestinginindividualsathighriskoffamilialalzheimersdiseasefromlatinamericaanonrandomizedcontrolledtrial
AT claudiacmadrigal impactofgeneticcounselingandtestinginindividualsathighriskoffamilialalzheimersdiseasefromlatinamericaanonrandomizedcontrolledtrial
AT juanpablopicasso impactofgeneticcounselingandtestinginindividualsathighriskoffamilialalzheimersdiseasefromlatinamericaanonrandomizedcontrolledtrial
AT claudiapramos impactofgeneticcounselingandtestinginindividualsathighriskoffamilialalzheimersdiseasefromlatinamericaanonrandomizedcontrolledtrial
AT carlosmrestrepofernandez impactofgeneticcounselingandtestinginindividualsathighriskoffamilialalzheimersdiseasefromlatinamericaanonrandomizedcontrolledtrial
AT gabrielavigo impactofgeneticcounselingandtestinginindividualsathighriskoffamilialalzheimersdiseasefromlatinamericaanonrandomizedcontrolledtrial
AT lauraramirezaguilar impactofgeneticcounselingandtestinginindividualsathighriskoffamilialalzheimersdiseasefromlatinamericaanonrandomizedcontrolledtrial
AT gabrielalbertovargascuadros impactofgeneticcounselingandtestinginindividualsathighriskoffamilialalzheimersdiseasefromlatinamericaanonrandomizedcontrolledtrial
AT mauricioarcosburgos impactofgeneticcounselingandtestinginindividualsathighriskoffamilialalzheimersdiseasefromlatinamericaanonrandomizedcontrolledtrial
AT erikamarianalongoria impactofgeneticcounselingandtestinginindividualsathighriskoffamilialalzheimersdiseasefromlatinamericaanonrandomizedcontrolledtrial
AT ellenziegemeier impactofgeneticcounselingandtestinginindividualsathighriskoffamilialalzheimersdiseasefromlatinamericaanonrandomizedcontrolledtrial
AT ericmcdade impactofgeneticcounselingandtestinginindividualsathighriskoffamilialalzheimersdiseasefromlatinamericaanonrandomizedcontrolledtrial
AT randalljbateman impactofgeneticcounselingandtestinginindividualsathighriskoffamilialalzheimersdiseasefromlatinamericaanonrandomizedcontrolledtrial
AT ricardofallegri impactofgeneticcounselingandtestinginindividualsathighriskoffamilialalzheimersdiseasefromlatinamericaanonrandomizedcontrolledtrial
AT franciscolopera impactofgeneticcounselingandtestinginindividualsathighriskoffamilialalzheimersdiseasefromlatinamericaanonrandomizedcontrolledtrial
AT jorgejllibreguerra impactofgeneticcounselingandtestinginindividualsathighriskoffamilialalzheimersdiseasefromlatinamericaanonrandomizedcontrolledtrial